Injection Versus Suture Repair of Laryngeal Clefts

NCT ID: NCT07057258

Last Updated: 2025-09-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Clinical Phase

NA

Total Enrollment

128 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-01

Study Completion Date

2026-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to learn more about a procedure that may be helpful for the participant's swallowing issues. The investigators are hoping to find out if one type of procedure is the same or better than another type of procedure at improving participant's issues with swallowing.

Participants will get one of two procedures. One is called injection laryngoplasty (IL) and injects a gel into the back wall of the participant's airway to prevent food and liquid from falling in. The other procedure is called endoscopic suture repair (ER) and uses sutures to sew together and build up the back wall of the participant's airway to prevent food and liquid from falling in. Participants will be asked to have a number of tests and procedures. These include a modified barium swallow study, in which the participant drinks and eats foods and liquids with barium in them and X-rays are used to assess how the food moves through the participant's body. This will be done before the procedure and 3 months after the procedure. The investigators will also give participants questionnaires to complete before and after the procedure.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study has 2 study groups.

* Group 1 will get IL for this condition.
* Group 2 will get ER for this condition

A computer will assign each participant to a group in no particular order. This is called randomization. Half of participants in this study will get IL. Half of participants will get ER. Each participant will have an equal chance of being in either group.

Neither the participants, the study doctor(s), nor the speech pathologist will know whether each participant will get the IL or ER. Only the surgeon will know which treatment the participant gets. The study is done this way because knowing which method the participant receives can change the results of the study.

If participants experience any serious side effects, the study doctor can find out which method they received so that any side effects can be treated properly.

Participants will need to have the following tests to find out if they can be in the study:

* Physical exam
* Demographic information/medical history
* Video fluoroscopic swallow study (VFSS) - X-ray videos that allow investigators to watch how food and liquids go down as a participant swallows them

If participant's screening tests show that they can take part in the study and they choose to be part of the study, they will also have to do the following tests:

* VFSS 3 months after the procedure
* Questionnaires asking about the emotional and physical burden of participant's swallowing issues, both before and after the procedure
* Overnight monitoring in the hospital after the procedure
* Follow up in clinic for up to 2 years after the procedure

Participant's medical records may be reviewed. Information reviewed may include treatment history, medications, surgeries, allergies, scans, and lab results.

Once participant's participation in the study ends, their medical provider(s) will help them choose the next step in their care.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Laryngeal Cleft Dysphagia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized controlled trial
Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Endoscopic suture repair

Children receiving endoscopic suture repair of laryngeal cleft

Group Type EXPERIMENTAL

Endoscopic suture repair

Intervention Type PROCEDURE

Children receiving endoscopic suture repair of laryngeal cleft

Injection laryngoplasty

Children receiving injection of the interarytenoid space of laryngeal cleft

Group Type ACTIVE_COMPARATOR

Injection laryngoplasty

Intervention Type PROCEDURE

Children receiving injection of the interarytenoid space for laryngeal cleft treatment

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Endoscopic suture repair

Children receiving endoscopic suture repair of laryngeal cleft

Intervention Type PROCEDURE

Injection laryngoplasty

Children receiving injection of the interarytenoid space for laryngeal cleft treatment

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* children aged 12 months - 10 years referred to a multi-disciplinary aerodigestive clinic with evidence of penetration or aspiration on VFSS, requiring any amount of thickening of liquids and unable to wean after 2-month trial of thickened liquids.

Exclusion Criteria

* Cerebral palsy
* Down syndrome
* Prematurity \< 28 weeks gestational age
* Hypoxic brain injury
* Any syndrome with significant hypotonia
* History of nothing by mouth (NPO) for \> 1 month prior to assessment
* \>50% of nutrition by G-tube
* Tracheostomy
* History of prior IL or ER
Minimum Eligible Age

12 Months

Maximum Eligible Age

10 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Oregon Health and Science University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Derek Lam, MD, MPH

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Oregon Health & Science University

Portland, Oregon, United States

Site Status

Vanderbilt University

Nashville, Tennessee, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

STUDY00027965

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Autologous Muscle Derived Cells for Treatment of Tongue Dysphagia
NCT05421689 ACTIVE_NOT_RECRUITING PHASE1/PHASE2